Claus serves as the Vice-Chair of the Board of Directors at the University Hospital Basel (USB), one of the world’s leading hospitals embedded in Europe’s eminent life-sciences hub; he is a member of the “Digitalization” as well as the “Research & Education” committee. A public servant for more than 12 years, Claus helped to shape Swissmedic’s role as an internationally respected “first-wave” reference agency as their Chief Medical Officer, previously Head of Marketing Authorization and Clinical Assessment as well as deputy Chief Executive. Swissmedic is a founding member of the Access Consortium (Australia's TGA, Health Canada, Singapore's HSA, the UK’s MHRA), also a Project Orbis Partner for the concurrent review of Oncology products coordinated by the US FDA. Prior to that, Claus had roles of increasing responsibilities with research-based international pharmaceutical, biotech and medical device organisations (UK, USA, CH). Claus trained as a General Surgeon and had international clinical and academic appointments in Trauma, Transplant and Oncologic Surgery. Thus, Claus can provide a 360-degree perspective on global product development and marketing: practitioner, developer, regulator, healthcare provider and well-connected networker. His credo: “Innovation in healthcare requires more than technology – it demands hands-on experience, strategic foresight, business acumen and regulatory expertise.”